Molecular Analysis of Retinoblastoma

Plain-language summary

This study examined the molecular features of retinoblastoma, an eye cancer, using tumor and blood samples. It was open to patients with a clinical diagnosis of retinoblastoma. Run by St. Jude Children's Research Hospital, it was a study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

St. Jude Children's Research Hospital

Intervention

Tissue samples taken from retinoblastoma, 5 ml peripheral blood

Start date

4/1/2007

Estimated completion

12/1/2016

Countries

Chile, Honduras

Related genes

Locations

• Santiago, Chile
• Tegucigalpa, Honduras

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Must have clinical diagnosis of retinoblastoma (to be confirmed histologically after enucleation)
* Legal guardians must willing to sign an informed consent indicating that they are aware of this study and its possible benefits. Legal guardians will be given a copy of the consent form.
* Patient is being seen at this AHOPCA institution:

Exclusion Criteria:

* Ophthalmologist or oncologist is concerned that sampling will interfere with staging.
* Diagnosis other than retinoblastoma.
* Affiliated hospital is unable to provide pathologic evidence of retinoblastoma.